Baric M, Sever AZ, Vuletic LB, Rasic Z, Sever M, Drmic D, Pavelic-Turudic T, Sucic M, Vrcic H, Seiwerth S, Sikiric P
Additionally, it has been associated with improvements in various metabolic factors, including blood sugar levels and blood pressure
So far, the mechanisms underlying the protective effects of GLP-1RA in respiratory disease are not fully understood
For the scientific community, the future involves: Continued Retatrutide Trials: Monitoring the outcomes of Retatrutide's Phase 3 clinical trials to understand its full efficacy and safety profile as a monotherapy
Sublingual dosing requires daily compliance and may produce more variable day-to-day effects